Chattem Q3 predictions
This article was originally published in The Tan Sheet
Executive Summary
Third quarter total revenue expected to reach $65 mil.-$67 mil., compared with previous guidance of $61 mil.-$63 mil. and year-ago sales of $49.6 mil., consumer products firm says in preliminary earnings release Sept. 12. "Strong results" were driven by Icy Hot, pHisoderm, Dexatrim and Gold Bond, "all of which experienced double-digit sales increases" over last year's Q3, Chattem says. EBITDA should reach $16 mil.-$17 mil. in Q3, compared with $11.3 mil. last year, firm predicts. FY 2003 revenue growth of 6%-8% is expected. Chattem will hold an earnings call on Sept. 27 to disclose full financial results, discuss its exit from ephedra market (1"The Tan Sheet" Sept. 9, 2002, p. 4)...